|
Volumn 128, Issue 6, 2004, Pages 949-950
|
Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right-heart dysfunction, and refractory hypoxemia after cardiothoracic surgery [1]
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIOXIDANT;
ILOPROST;
NITRIC OXIDE;
PEROXYNITRITE;
PROSTACYCLIN;
REACTIVE NITROGEN SPECIES;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;
SUPEROXIDE;
ANTIOXIDANT ACTIVITY;
CELL MIGRATION;
CELL PROLIFERATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
ENZYME ACTIVITY;
ENZYME INHIBITION;
GRAFT REJECTION;
HEART DISEASE;
HEART LEFT VENTRICLE FUNCTION;
HUMAN;
HYPOXEMIA;
INFLAMMATION;
LETTER;
LEUKOCYTE ADHERENCE;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PULMONARY HYPERTENSION;
SMOOTH MUSCLE FIBER;
THORAX SURGERY;
THROMBOCYTE ADHESION;
UPREGULATION;
ANOXEMIA;
ANTIHYPERTENSIVE AGENTS;
CARDIAC SURGICAL PROCEDURES;
EPOPROSTENOL;
HUMANS;
HYPERTENSION, PULMONARY;
VENTRICULAR DYSFUNCTION, RIGHT;
VENTRICULAR FUNCTION, LEFT;
|
EID: 9644258875
PISSN: 00225223
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jtcvs.2004.05.035 Document Type: Letter |
Times cited : (9)
|
References (8)
|